お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
997986

肥満治療市場:手術・医薬品・エンドユーザー・地域別の規模・シェア・予測 - COVID-19による影響の分析 (2021-2027年)

Obesity Treatment Market with COVID-19 Impact Analysis, By Surgery, By Drugs, By End User, and By Region - Size, Share, & Forecast from 2021-2027

出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 300 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.33円
肥満治療市場:手術・医薬品・エンドユーザー・地域別の規模・シェア・予測 - COVID-19による影響の分析 (2021-2027年)
出版日: 2021年03月01日
発行: AnalystView Market Insights
ページ情報: 英文 300 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界における肥満治療の市場規模は、2020年に76億3000万米ドルと評価され、2021年から2027年の予測期間中に16.3%のCAGRで成長する見込みです。

肥満治療市場は、高度な技術の採用増加と低侵襲手術の採用により、今後数年間で大幅な成長を遂げると推定されています。さらに、肥満手術に対する意識の高まりも市場の成長を後押しすると予測されています。 Institute of Health Metrics and Evaluationによると、世界の総人口の約30.0%を占める約21億人が、太りすぎまたは肥満です。中低所得国では、肥満が大きな課題となっています。 WHOのデータによると、肥満または肥満状態は、より高い死亡率に寄与するさまざまな障害につながります。

当レポートでは、世界の肥満治療市場について調査分析し、市場概要、市場規模と予測、セグメント別の市場分析、地域別の市場分析、競合情勢などについて、体系的な情報を提供しています。

目次

第1章 肥満治療の市場概要

第2章 エグゼクティブサマリー

  • 市場内訳
    • 市場内訳:手術別
    • 市場内訳:医薬品別
    • 市場内訳:エンドユーザー別
    • 市場内訳:地域別
  • 競合考察

第3章 肥満治療の主な市場動向

  • 市場成長促進要因
    • 市場成長要因の影響分析
  • 市場抑制要因
    • 市場抑制要因の影響分析
  • 市場機会
  • 市場の将来動向

第4章 肥満治療業界の調査

  • ポーターのファイブフォース分析
  • マーケティング戦略分析
  • 成長展望マッピング
  • 規制の枠組み分析

第5章 肥満治療市場:COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以降の影響分析
    • トップパフォーマンスセグメント
    • 限界成長セグメント
    • トップルーザーセグメント
    • 限界損失セグメント

第6章 肥満治療:市場情勢

  • 市場シェア分析
  • 主なイノベーターの分析
  • 内訳データ:主要メーカー別
    • 既存企業分析
    • 新興企業分析

第7章 肥満治療市場:手術別

  • 概要
  • 胃バンディングの調整
  • 内視鏡的処置
  • ルーワイ胃バイパス術
  • スリーブ状胃切除術
  • 十二指腸スイッチ別胆膵管転換

第8章 肥満治療市場:医薬品別

  • 概要
  • 食欲抑制剤
  • 吸収不良
  • 併用薬
  • 満腹薬

第9章 肥満治療市場:エンドユーザー別

  • 概要
  • 病院
  • クリニック
  • その他

第10章 肥満治療市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋(APAC)
  • ラテンアメリカ
  • 中東・アフリカ

第11章 ベンダー分析

  • 競争力ダッシュボード
  • 企業プロファイル
    • Olympus Corporation
    • F. Hoffmann-La Roche, Ltd.
    • Cousin Biotech
    • Johnson & Johnson Services, Inc.
    • EnteroMedics, Inc.
    • Novo Nordisk A/S
    • Arena Pharmaceuticals, Inc.
    • VIVUS, Inc.
    • Allergan
    • Orexigen Therapeutics, Inc.
    • Medtronic
    • USGI Medical, Inc.
    • Covidien plc
    • Mediflex Surgical Products

第12章 アナリストの全方位的展望

第13章 付録

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Obesity Treatment market: Surgerys Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Surgerys
  • TABLE Global Obesity Treatment market, by Surgerys 2016-2027 (USD Million)
  • TABLE Obesity Treatment market: Drugs Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Drugs
  • TABLE Global Obesity Treatment market, by Drugs 2016-2027 (USD Million)
  • TABLE Obesity Treatment market: Regional snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Obesity Treatment market, by Region 2016-2027 (USD Million)
  • TABLE North America Obesity Treatment market, by Country, 2016-2027 (USD Million)
  • TABLE North America Obesity Treatment market, by Surgerys, 2016-2027 (USD Million)
  • TABLE North America Obesity Treatment market, By Drugs,2016-2027 (USD Million)
  • TABLE Europe Obesity Treatment market, by Country, 2016-2027 (USD Million)
  • TABLE Europe Obesity Treatment market, by Surgerys, 2016-2027 (USD Million)
  • TABLE Europe Obesity Treatment market, By Drugs,2016-2027 (USD Million)
  • TABLE Asia Pacific Obesity Treatment market, by Country, 2016-2027 (USD Million)
  • TABLE Asia Pacific Obesity Treatment market, by Surgerys, 2016-2027 (USD Million)
  • TABLE Asia Pacific Obesity Treatment market, By Drugs,2016-2027 (USD Million)
  • TABLE Latin America Obesity Treatment market, by Country, 2016-2027 (USD Million)
  • TABLE Latin America Obesity Treatment market, by Surgery, 2016-2027 (USD Million)
  • TABLE Latin America Obesity Treatment market, By Drugs,2016-2027 (USD Million)
  • TABLE Middle East and Africa Obesity Treatment market, by Country, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Obesity Treatment market, by Surgery, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Obesity Treatment market, By Drugs,2016-2027 (USD Million)

List of Figures

  • FIGURE Obesity Treatment market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2019
  • FIGURE Surgery segment market share analysis, 2020 & 2027
  • FIGURE Surgery segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Drugs segment market share analysis, 2020 & 2027
  • FIGURE Drugs segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Regional segment market share analysis, 2020 & 2027
  • FIGURE Regional segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE North America Obesity Treatment market share and leading players, 2019
  • FIGURE Europe Obesity Treatment market share and leading players, 2019
  • FIGURE Asia Pacific Obesity Treatment market share and leading players, 2019
  • FIGURE Latin America Obesity Treatment market share and leading players, 2019
  • FIGURE Middle East and Africa Obesity Treatment market share and leading players, 2019
  • FIGURE North America market share analysis by country, 2019
  • FIGURE U.S. Obesity Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Canada Obesity Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Europe Obesity Treatment market share analysis by country, 2019
  • FIGURE Germany Obesity Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Spain Obesity Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Italy Obesity Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE UK Obesity Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE France Obesity Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of the Europe Obesity Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Asia Pacific Obesity Treatment market share analysis by country, 2019
  • FIGURE India Obesity Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE China Obesity Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Japan Obesity Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE South Korea Obesity Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Singapore Obesity Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of APAC Obesity Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America Obesity Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America Obesity Treatment market share analysis by country, 2019
  • FIGURE Brazil Obesity Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Mexico Obesity Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Argentina Obesity Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of LATAM Obesity Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa Obesity Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa Obesity Treatment market share analysis by country, 2019
  • FIGURE Saudi Arabia Obesity Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE United Arab Emirates Obesity Treatment market size, forecast and trend analysis, 2016 to 2027 (USD Million)
目次

REPORT HIGHLIGHT

The global obesity treatment market was valued at USD 7.63 billion in 2020, growing with 16.3% CAGR during the forecast period, 2021-2027.

Obesity is a kind of disease caused due to extreme body fat content. The key factors determining the existence & the severity of obesity are body mass index, waist circumference, waist-to-height ratio, and other degenerative health conditions.

The obesity treatment market is estimated to witness significant growth in the next few years, owing to the rising adoption of advanced technology & adoption of minimally invasive procedures. In addition, the growing awareness about bariatric surgeries is also projected to boost the market growth. According to the Institute of Health Metrics and Evaluation, around 2.1 billion people which accounts for nearly 30.0% of the total world's population are either overweight or obese. In the middle- & low-income countries obesity is imposing a huge challenge. According to WHO data, obesity or obese conditions leads to various disorders that contribute to a greater mortality rate.

Several medical problems, genetics, inactivity, family lifestyle, medications, age, unhealthy diet, and pregnancy may lead to obesity. Moreover, obese conditions increase the risk of heart disease, diabetes, stroke, arthritis, and cancers. Obesity treatment is incorporated in two steps such as assessment & management. The obesity assessment involves the determination of the level of obesity while obesity management includes the overall maintenance of body weight. Further, the supportive government initiatives about creating awareness regarding fitness & health, and technological development is expected to positively impact market growth.

The obesity treatment market is differentiated into surgery, drugs, and end-user segments. Based on the surgery, the endoscopic procedures segment held the largest market share in 2019. By drugs, the malabsorption segment is anticipated to offer ample growth opportunities for the market.

Regional Insights

North America dominated the global market with market share in 2019. The rising obese population and overweight concerns are driving the market growth. In addition, the growing prevalence of diabetes and hypertension is projected to contribute to market growth. Europe is the second-largest market in 2019. On the other side, Asia Pacific is estimated to grow at the highest CAGR over the forecast period. The increasing awareness levels across the developing countries and growing demand for bariatric surgeries is projected to bolster the market growth.

Competitive Landscape

The obesity treatment market is moderately competitive in nature with the presence of domestic players and global players. Key companies in the industry mainly focus on strategic innovation, mergers & acquisition activities, product expansion to remain competent in the market. Top players in the market including Arena Pharmaceuticals, Inc., VIVUS, Inc., F. Hoffmann-La Roche Ltd., Medtronic, Novo Nordisk A/S, Allergan Plc, are holding the majority of the market share. In addition, several players focus on investment in R&D to develop new safety & drug products.

Key features of the study:

This proposed research study on Obesity Treatment market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2020-2027), considering 2019 as the base year

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Obesity Treatment market

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Obesity Treatment market

Impact of COVID-19 on Obesity Treatment market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Obesity Treatment market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the Obesity Treatment market, we have also included competitive landscape and key innovator analysis for the Obesity Treatment market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and end-user's attractiveness.

The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Obesity Treatment market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new product launch, research & development, regional expansion of major participants involved in the Obesity Treatment market on global as well as regional level.

The global Obesity Treatment market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL OBESITY TREATMENT MARKET KEY PLAYERS

Olympus Corporation

F. Hoffmann-La Roche, Ltd.

Cousin Biotech

Johnson & Johnson Services, Inc.

EnteroMedics, Inc.

Novo Nordisk A/S

Arena Pharmaceuticals, Inc.

VIVUS, Inc.

Allergan

Orexigen Therapeutics, Inc.

Medtronic

USGI Medical, Inc.

Covidien plc

Mediflex Surgical Products

GLOBAL OBESITY TREATMENT MARKET, BY SURGERY

Adjusting gastric Banding

Endoscopic Procedures

Roux-en-Y Gastric Bypass

Sleeve gastrectomy

Biliopancreatic diversion with Duodenal Switch

GLOBAL OBESITY TREATMENT MARKET, BY DRUGS

Appetite suppressants

Malabsorption

Combination drugs

Satiety drugs

GLOBAL OBESITY TREATMENT MARKET, BY END USER

Hospitals

Clinics

Others

GLOBAL OBESITY TREATMENT MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Singapore

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

The Middle East and Africa

Saudi Arabia

United Arab Emirates

Rest of MEA

TABLE OF CONTENT

1. Obesity Treatment Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Surgery
    • 2.1.2. Market Snippet by Drugs
    • 2.1.3. Market Snippet by End User
    • 2.1.4. Market Snippet by Region
  • 2.2. Competitive Insights

3. Obesity Treatment Key Market Trends

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. Obesity Treatment Industry Study

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Obesity Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Obesity Treatment Market Landscape

  • 6.1. Market Share Analysis, 2019
  • 6.2. Key Innovators Analysis
  • 6.3. Breakdown Data, by Key Manufacturer
    • 6.3.1. Established Players' Analysis
    • 6.3.2. Emerging Players' Analysis

7. Obesity Treatment Market - By Surgery

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Surgery, 2020 & 2027 (%)
  • 7.2. Adjusting gastric Banding
  • 7.3. Endoscopic Procedures
  • 7.4. Roux-en-Y Gastric Bypass
  • 7.5. Sleeve gastrectomy
  • 7.6. Biliopancreatic diversion with Duodenal Switch

8. Obesity Treatment Market - By Drugs

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Drugs, 2020 & 2027 (%)
  • 8.2. Appetite suppressants
  • 8.3. Malabsorption
  • 8.4. Combination drugs
  • 8.5. Satiety drugs

9. Obesity Treatment Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2020 & 2027 (%)
  • 9.2. Hospitals
  • 9.3. Clinics
  • 9.4. Others

10. Obesity Treatment Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2020 & 2027 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Surgery, 2016 - 2027 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Drugs,2016 - 2027 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User,2016 - 2027 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Surgery, 2016 - 2027 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Drugs,2016 - 2027 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User,2016 - 2027 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Surgery, 2016 - 2027 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Drugs,2016 - 2027 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User,2016 - 2027, (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Surgery, 2016 - 2027 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Drugs,2016 - 2027 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User,2016 - 2027 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Surgery, 2016 - 2027 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Drugs,2016 - 2027 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User,2016 - 2027 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Surgery, 2016 - 2027 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Drugs,2016 - 2027 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User,2016 - 2027 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Surgery, 2016 - 2027 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Drugs,2016 - 2027 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User,2016 - 2027 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Surgery, 2016 - 2027 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Drugs,2016 - 2027 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User,2016 - 2027 (US$ Million)
    • 10.3.11. Rest of Europe
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.3.11.3. Rest of the Europe Market Size and Forecast, By Surgery, 2016 - 2027 (US$ Million)
      • 10.3.11.4. Rest of the Europe Market Size and Forecast, By Drugs,2016 - 2027 (US$ Million)
      • 10.3.11.5. Rest of the Europe Market Size and Forecast, By End User,2016 - 2027 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Surgery, 2016 - 2027 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Drugs,2016 - 2027 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User,2016 - 2027 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Surgery, 2016 - 2027 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Drugs,2016 - 2027 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User,2016 - 2027 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Surgery, 2016 - 2027 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Drugs,2016 - 2027 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User,2016 - 2027 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Surgery, 2016 - 2027 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Drugs,2016 - 2027 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User,2016 - 2027 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Surgery, 2016 - 2027 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Drugs,2016 - 2027 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User,2016 - 2027 (US$ Million)
    • 10.4.11. Rest of APAC
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.4.11.3. Rest of APAC Market Size and Forecast, By Surgery, 2016 - 2027 (US$ Million)
      • 10.4.11.4. Rest of APAC Market Size and Forecast, By Drugs,2016 - 2027 (US$ Million)
      • 10.4.11.5. Rest of APAC Market Size and Forecast, By End User,2016 - 2027 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Surgery, 2016 - 2027 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Drugs,2016 - 2027 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User,2016 - 2027 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Surgery, 2016 - 2027 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Drugs,2016 - 2027 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User,2016 - 2027 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Surgery, 2016 - 2027 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Drugs,2016 - 2027 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User,2016 - 2027 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Surgery, 2016 - 2027 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Drugs,2016 - 2027 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User,2016 - 2027 (US$ Million)
    • 10.5.10. Rest of LATAM
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.5.10.3. Rest of LATAM Market Size and Forecast, By Surgery, 2016 - 2027 (US$ Million)
      • 10.5.10.4. Rest of LATAM Market Size and Forecast, By Drugs,2016 - 2027 (US$ Million)
      • 10.5.10.5. Rest of LATAM Market Size and Forecast, By End User,2016 - 2027 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Surgery, 2016 - 2027 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Drugs,2016 - 2027 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User,2016 - 2027 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Surgery, 2016 - 2027 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Drugs,2016 - 2027 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User,2016 - 2027 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Surgery, 2016 - 2027 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Drugs,2016 - 2027 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User,2016 - 2027 (US$ Million)

11. Key Vendor Analysis

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Olympus Corporation
    • 11.2.2. F. Hoffmann-La Roche, Ltd.
    • 11.2.3. Cousin Biotech
    • 11.2.4. Johnson & Johnson Services, Inc.
    • 11.2.5. EnteroMedics, Inc.
    • 11.2.6. Novo Nordisk A/S
    • 11.2.7. Arena Pharmaceuticals, Inc.
    • 11.2.8. VIVUS, Inc.
    • 11.2.9. Allergan
    • 11.2.10. Orexigen Therapeutics, Inc.
    • 11.2.11. Medtronic
    • 11.2.12. USGI Medical, Inc.
    • 11.2.13. Covidien plc
    • 11.2.14. Mediflex Surgical Products

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.